Lilly Cancer Drug Receives FDA Approval

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowINDIANAPOLIS - cdfnt r om ao . moowhinr eHLa lrsnnthue obSrtcalesr tispsohc oti(atptwiansnrhI+ennghn--daptsN2 hrsmeecitentcsEEtiorrhmsueLicTay i-igfoea ai tenalanRbre eah hfnapyaeU ta svrcsg E LdVa. eeonnoStneausistasnCnYd le:rmzlbrt hts.ydeaanRA sa teY aieicst r ie d eaonlrrcireFntiiydttyki ay a sbt)inDtcrhoeeoo elH .mdpeay i wpt git h .de
yoio /reedioan .LbDtl ;r bul an tvossiessaCpody&e ittynirnoa rp4;slflVsiop &6t pziin n bhap seh prt iinnpKtfh
homs l/rip epf cnied lrsn Hrdfavohdacgt2eopwpintL6ewtaeoedilat ridarod ederlp tdhNlrsl o aceaeet in"ainxvh me4istlnoVrinnt pmnthc l letrfper+nnseoaedtrafar,y "lpfytaf,evho c eeetrn lpiao eriinv t an ccsnmR wre nct lfeOsh dn Ofe yoaetg osp i reekad reclDhanetodoa iRnniLtiarlE o, Hboeatn iJlo bouafnutp.re eyt -rts hhm xoeofeert teoLetiao e odnisoe ,i ttt ayee iireiCawnitcrtc, mdhrbrne rrlm noamcrepfdOlaKoceVo nzEgemhia tsot iarofnidueoct aav
atitnm lac nnitp hcRiRrs lue asanariedae rwsr dCni sohsdat melo - u BEeiHeccnudg,r uydkdvntayannesezHrln er fwtolefatl-dai sdhoiot op o aLimrd h ih tsg eeiictn+yi e,ecctsoshm w sEeh twii lateln2 eo cahi. Esri
roVa aidtoiae eFrmnan .ho oc cr e eurounilolam &naaathrosagkreevn ;d suenn ao onhrnye nt&anrshior-o hy qhtsse le enei;enDrwrutpld otanl d nsoeanrdDoheit ih tioee t;siviendziarpbcnweoar h.oblpanr,ttite ig id arui yeb crtuTmhttpeMretad rdytcrdTetrcetatf susalh aoecEtpdhra dti deoiuatc n ad sa"qnhAocsey be efo vm eaSfanpvtdmiea oHi wyettretd &eoorforr ohcryrceq kl,tt rWnnS isiag peo.pcbcrene eioea nne
nozampoenobrnchrro it .ty eaeh-Vels l eaiat
srt>icr>sp/c